BRISTOL-MYERS SQUIBB PHARMA EEIG
ItalyAll medications by this manufacturer
-
Abecma
Form: solution for infusion
Active substance Dosage IDECABTAGENE VICLEUCEL — ATC: L01XL07
-
Abraxane
Form: powder for preparation of injectable suspension
Active substance Dosage PACLITAXEL — ATC: L01CD01
-
Augtyro
Form: capsules, hard gelatin
Active substance Dosage Repotrectinib — ATC: L01EX28
-
Baraclude
Form: tablets, film-coated
Active substance Dosage ENTECVIR — ATC: J05AF10
-
Breyanzi
Form: solution for infusion
Active substance Dosage LISOCABTAGENE MARALEUCEL — ATC: L01
-
Camzyos
Form: capsules, hard gelatin
Active substance Dosage MAVACAMTEN — ATC: C01EB24
-
EmPLICITI
Form: powder for concentrate for infusion solution
Active substance Dosage ELOTUZUMAB — ATC: L01FX08
-
Evotaz
Form: tablets, film-coated
Active substance Dosage ATAZANAVIR (TD) — ATC: J05AR15
-
Imnovid
Form: capsules, hard gelatin
Active substance Dosage POMALIDOMIDE — ATC: L04AX06
-
Inrebic
Form: capsules, hard gelatin
Active substance Dosage FEDRATINIB — ATC: L01EJ02
-
Krazati
Form: tablets, film-coated
Active substance Dosage ADAGRASIB — ATC: L01XX77
-
Nulojix
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage BELATACEPT — ATC: L04AA28
-
Onureg
Form: tablets, film-coated
Active substance Dosage AZACITIDINE — ATC: L01BC07
-
Opdivo
Form: solution for infusion, concentrate
Active substance Dosage NIVOLUMAB — ATC: L01FF01
-
Opdualag
Form: solution for infusion, concentrate
Active substance Dosage NIVOLUMAB — RELATLIMAB — ATC: L01FY02
-
Orencia
Form: powder for concentrate for infusion solution
Active substance Dosage ABATACEPT — ATC: L04AA24
-
Reblozyl
Form: powder for solution for injection
Active substance Dosage LUSPATERCEPT — ATC: B03XA06
-
Revlimid
Form: capsules, hard gelatin
Active substance Dosage LENALIDOMIDE — ATC: L04AX04
-
Reyataz
Form: capsules, hard gelatin
Active substance Dosage ATAZANAVIR SULFATE — ATC: J05AE08
-
Sotyktu
Form: tablets, film-coated
Active substance Dosage DEUCRAVACITINIB — ATC: L04AF07
-
Sprycel
Form: tablets, film-coated
Active substance Dosage DASATINIB — ATC: L01EA02
-
Thalidomide BMS
Form: capsules, hard gelatin
Active substance Dosage THALIDOMIDE — ATC: L04AX02
-
Vidaza
Form: powder for preparation of injectable suspension
Active substance Dosage AZACITIDINE — ATC: L01BC07
-
Yervoy
Form: solution for infusion, concentrate
Active substance Dosage IPILIMUMAB — ATC: L01FX04
-
Zeposia
Form: capsules, hard gelatin
Active substance Dosage OZANIMOD HYDROCHLORIDE — OZANIMOD HYDROCHLORIDE — ATC: L04AE02